MétaCan
Menu
Back to cohort
Record W4414800130 · doi:10.1093/neuonc/noaf193.466

P14.05.B CAR T-CELL THERAPY DOES NOT LEAD TO MEDIUM-TERM NEUROCOGNITIVE DETERIORATION IN PATIENTS WITH CENTRAL NERVOUS SYSTEM LYMPHOMAS. A LOC NETWORK STUDY

2025· article· en· W4414800130 on OpenAlexaboutno aff
Caroline Houillier, Sirine Mersali, Rémy Chapelle, Monica Ribeiro, Nicolas Weiss, Dimitri Psimaras, Loïc Le Guennec, Cristina Birzu, Khê Hoang‐Xuan, Ines Boussen, Marine Baron, Véronique Morel, Madalina Uzunov, Valérie Friser, Sylvain Choquet

Bibliographic record

VenueNeuro-Oncology · 2025
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicGene Regulatory Network Analysis
Canadian institutionsnot available
Fundersnot available
KeywordsNeurocognitiveNeuropsychologyNeurotoxicityCentral nervous systemLymphomaPrimary central nervous system lymphoma

Abstract

fetched live from OpenAlex

Abstract BACKGROUND Several recent studies have shown promising efficacy of anti-CD19 chimeric antigen receptor (CAR) T-cell therapy in central nervous system (CNS) lymphomas. Data regarding neurotoxicity were reassuring, with rates of severe acute neurotoxicity similar to those described in systemic lymphomas. However, recently published data from our group outlined the risk of prolonged neurologic deterioration in patients who experienced severe neurotoxicity, which is unusual in systemic lymphomas. The aim of this study was to evaluate mid-term neurocognitive outcomes in CNS lymphomas treated with CAR T-cells. MATERIAL AND METHODS Patients were retrospectively selected from the French LOC network database according to the following criteria: 1) CNS lymphoma treated with CAR T-cells at Pitié-Salpêtrière hospital; 2) Isolated CNS relapse at the time of leukapheresis; 3) Availability of neuropsychological follow-up. Neuropsychological assessment was performed as part of the usual care, before CAR T-cell infusion and, in the absence of tumoral progression, 6 weeks (W6), 6 months (M6) and 12 months (M12) after CAR T-cell therapy. RESULTS Of 38 CNS lymphomas who received CAR T-cells between May 2021 and March 2024, 30 patients (median age: 61 years (range: 30-82), 17 women, 14 primary, 16 secondary CNS lymphomas) benefited from repeated neuropsychological assessments. At the time of CAR T-cell infusion, 7 had stable or progressive disease, median Karnofsky Performance Status (KPS) was 75 and median Montreal Cognitive Assessment (MoCA) score was 23.5 (range: 11-29). Eleven patients received tisagenlecleucel, 17 axicabtagene ciloleucel and 2 brexucabtagene autoleucel. Nineteen patients experienced acute neurotoxicity, including 6 cases of grade 3-4 neurotoxicity. Twenty-two patients were assessed up to M12 (all other patients progressed). Clustering of these longitudinal data using a k-means approach revealed at W6 a subgroup of patients (n=22) with stable or improved cognitive functioning and a subgroup (n=8) with worsened cognitive functioning. Membership to these clusters was strongly associated with the occurrence and severity of an acute neurotoxicity (p=0.01). At M12, there was a statistically significant improvement of MoCA score (median 26 vs 23.5, p<0.001) compared to baseline. Scores addressing memory, executive functions, visuo-spatial functions and anxiety/depression also improved, although not significantly. Such improvements were already seen at M6, and applied both to the whole population and to the subgroup who experienced grade 3-4 neurotoxicity. CONCLUSION Mid-term neurocognition follow-up of patients with CNS lymphoma treated by CAR T-cells seems reassuring, with no significant cognitive worsening, even in patients who experienced severe acute neurotoxicity. These results should be confirmed with longer follow-up.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.242
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.006
GPT teacher head0.232
Teacher spread0.226 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueNeuro-OncologySame topicGene Regulatory Network AnalysisFrench-language works237,207